CH605833A5 - - Google Patents
Info
- Publication number
- CH605833A5 CH605833A5 CH1358675A CH1358675A CH605833A5 CH 605833 A5 CH605833 A5 CH 605833A5 CH 1358675 A CH1358675 A CH 1358675A CH 1358675 A CH1358675 A CH 1358675A CH 605833 A5 CH605833 A5 CH 605833A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES432334A ES432334A1 (es) | 1974-11-27 | 1974-11-27 | Procedimiento de obtencion de derivados 1-amido alquil-4- sulfonil-piperazina. |
Publications (1)
Publication Number | Publication Date |
---|---|
CH605833A5 true CH605833A5 (xx) | 1978-10-13 |
Family
ID=8468076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1358675A CH605833A5 (xx) | 1974-11-27 | 1975-10-20 |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS5165778A (xx) |
CH (1) | CH605833A5 (xx) |
DE (1) | DE2545329A1 (xx) |
ES (1) | ES432334A1 (xx) |
FR (1) | FR2292477A1 (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56157809U (xx) * | 1980-04-24 | 1981-11-25 | ||
US5648352A (en) * | 1991-09-13 | 1997-07-15 | Merck & Co., Inc. | Piperazinylcamphorsulfonyl oxytocin antagonists |
EP0533242A3 (en) * | 1991-09-16 | 1993-09-15 | Merck & Co. Inc. | Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
EP0533241A3 (en) * | 1991-09-16 | 1993-09-29 | Merck & Co. Inc. | Substituted alkyl derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
EP0533240A3 (en) * | 1991-09-16 | 1993-09-29 | Merck & Co. Inc. | Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
ATE216580T1 (de) * | 1993-07-16 | 2002-05-15 | Merck & Co Inc | Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten |
CA2166974A1 (en) * | 1993-07-16 | 1995-01-26 | Mark G. Bock | Substituted amide derivatives of piperizinylcamphor sulfonyl and carbonyl oxytocin antagonists |
US5464788A (en) * | 1994-03-24 | 1995-11-07 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
KR20010025140A (ko) * | 2000-02-11 | 2001-04-06 | 남홍길 | 보르네올 또는 캄포를 유효성분으로 하는 니코틴 수용체길항제 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES374515A1 (es) * | 1969-12-12 | 1972-01-01 | Liade Sa Lab | Procedimiento de obtencion de nuevos compuestos con accio- nes cardiovasculares. |
-
1974
- 1974-11-27 ES ES432334A patent/ES432334A1/es not_active Expired
-
1975
- 1975-03-27 JP JP50036149A patent/JPS5165778A/ja active Granted
- 1975-10-02 FR FR7530224A patent/FR2292477A1/fr active Granted
- 1975-10-09 DE DE19752545329 patent/DE2545329A1/de active Pending
- 1975-10-20 CH CH1358675A patent/CH605833A5/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2292477B1 (xx) | 1979-09-14 |
JPS541317B2 (xx) | 1979-01-23 |
DE2545329A1 (de) | 1976-08-12 |
JPS5165778A (en) | 1976-06-07 |
ES432334A1 (es) | 1976-11-01 |
FR2292477A1 (fr) | 1976-06-25 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |